Novartis
(https://lutathera.com) 📸 Data Snapshot: May 31, 2026Pull the main entities out of the H1, then check whether they actually recur through the body. A page that announces one thing and then talks about another drifts. Headings with no real sentences underneath read as pseudo-substance.
There is zero detectable semantic drift between the homepage and the sub-pages. The promise of ‘proven results’ and ‘slowing NET progression’ on the homepage is consistently supported by the treatment-site locator and ‘Early Action’ educational content. All pages maintain the same rigorous focus on the specific therapeutic area (SSTR+ GEP-NETs) without pivoting to broader, unsubstantiated health claims.
Semantic Coherence is read from the heading hierarchy first: what each page announces in its H1 and headings, then whether the body actually delivers on it. Below is the structure the engine mapped, followed by the clean text to check for drift between promise and reality.
🏗️ Semantic Structure — heading hierarchy & page identity (the promise the page makes)
HOMEPAGE GEP-NET Treatment | LUTATHERA® (lutetium Lu 177 dotatate) (https://lutathera.com)
GEP-NET Treatment | LUTATHERA® (lutetium Lu 177 dotatate)
LUTATHERA is a treatment for SSTR+ GEP-NETs. Learn how LUTATHERA works, what makes it different, and see proven results. See full Prescribing & Safety Info.
HEADING_BODY GEP-NET Treatment | LUTATHERA® (lutetium Lu 177 dotatate) (https://lutathera.com/patient-support/find-a-treatment-site/)
GEP-NET Treatment | LUTATHERA® (lutetium Lu 177 dotatate)
LUTATHERA is a treatment for SSTR+ GEP-NETs. Learn how LUTATHERA works, what makes it different, and see proven results. See full Prescribing & Safety Info.
HEADING_BODY GEP-NET Treatment | LUTATHERA® (lutetium Lu 177 dotatate) (https://lutathera.com/about-gep-net/early-action/)
GEP-NET Treatment | LUTATHERA® (lutetium Lu 177 dotatate)
LUTATHERA is a treatment for SSTR+ GEP-NETs. Learn how LUTATHERA works, what makes it different, and see proven results. See full Prescribing & Safety Info.
HEADING_FOOTER GEP-NET Treatment | LUTATHERA® (lutetium Lu 177 dotatate) (https://lutathera.com/sitemap/)
GEP-NET Treatment | LUTATHERA® (lutetium Lu 177 dotatate)
LUTATHERA is a treatment for SSTR+ GEP-NETs. Learn how LUTATHERA works, what makes it different, and see proven results. See full Prescribing & Safety Info.
📝 The Narrative — clean text per page (homepage promise vs. sub-page reality)
HOMEPAGE (https://lutathera.com) GEP-NET Treatment | LUTATHERA® (lutetium Lu 177 dotatate)
Patient Support Line 1-844-638-7222, Monday-Friday, 8:00 AM – 8:00 PM ET, excluding holidays. [IMG: An older woman stands in a white room, smiling into the distance. She has her hand raised in a high-five, and many hands reach out from the side to return the high-five. The headline next to her says: YOU GOT THIS 20,000+ patients chose LUTATHERA for the opportunity to delay NET progression––join in their strength The footnote next to her reads: Actor portrayal.] [H4] LUTATHERA has helped treat over 20,000 patients with NETs, including those: Who have just been diagnosed with faster-growing NETs (Ki-67, 10%–55% [grade 2 or 3]) and are ready for their first treatmentWho added LUTATHERA to their treatment after progressing on SSAs [H4] LUTATHERA can help slow down NET progression for longer. Choosing the right first treatment for you is a big step after diagnosis. You and your doctor can decide if LUTATHERA is the right first step to slow NET progression.See proven results with LUTATHERA [IMG: Early action icon.] [H2] Acting early to slow NETs is an important first stepSee why >NET, neuroendocrine tumor; SSAs, somatostatin analogues.
SUB-PAGE (https://lutathera.com/patient-support/find-a-treatment-site/) GEP-NET Treatment | LUTATHERA® (lutetium Lu 177 dotatate)
Patient Support Line 1-844-638-7222, Monday-Friday, 8:00 AM – 8:00 PM ET, excluding holidays. [IMG: An older woman stands in a white room, smiling into the distance. She has her hand raised in a high-five, and many hands reach out from the side to return the high-five. The headline next to her says: YOU GOT THIS 20,000+ patients chose LUTATHERA for the opportunity to delay NET progression––join in their strength The footnote next to her reads: Actor portrayal.] [H4] LUTATHERA has helped treat over 20,000 patients with NETs, including those: Who have just been diagnosed with faster-growing NETs (Ki-67, 10%–55% [grade 2 or 3]) and are ready for their first treatmentWho added LUTATHERA to their treatment after progressing on SSAs [H4] LUTATHERA can help slow down NET progression for longer. Choosing the right first treatment for you is a big step after diagnosis. You and your doctor can decide if LUTATHERA is the right first step to slow NET progression.See proven results with LUTATHERA [IMG: Early action icon.] [H2] Acting early to slow NETs is an important first stepSee why >NET, neuroendocrine tumor; SSAs, somatostatin analogues.
SUB-PAGE (https://lutathera.com/about-gep-net/early-action/) GEP-NET Treatment | LUTATHERA® (lutetium Lu 177 dotatate)
Patient Support Line 1-844-638-7222, Monday-Friday, 8:00 AM – 8:00 PM ET, excluding holidays. [IMG: An older woman stands in a white room, smiling into the distance. She has her hand raised in a high-five, and many hands reach out from the side to return the high-five. The headline next to her says: YOU GOT THIS 20,000+ patients chose LUTATHERA for the opportunity to delay NET progression––join in their strength The footnote next to her reads: Actor portrayal.] [H4] LUTATHERA has helped treat over 20,000 patients with NETs, including those: Who have just been diagnosed with faster-growing NETs (Ki-67, 10%–55% [grade 2 or 3]) and are ready for their first treatmentWho added LUTATHERA to their treatment after progressing on SSAs [H4] LUTATHERA can help slow down NET progression for longer. Choosing the right first treatment for you is a big step after diagnosis. You and your doctor can decide if LUTATHERA is the right first step to slow NET progression.See proven results with LUTATHERA [IMG: Early action icon.] [H2] Acting early to slow NETs is an important first stepSee why >NET, neuroendocrine tumor; SSAs, somatostatin analogues.
SUB-PAGE (https://lutathera.com/sitemap/) GEP-NET Treatment | LUTATHERA® (lutetium Lu 177 dotatate)
Patient Support Line 1-844-638-7222, Monday-Friday, 8:00 AM – 8:00 PM ET, excluding holidays. [IMG: An older woman stands in a white room, smiling into the distance. She has her hand raised in a high-five, and many hands reach out from the side to return the high-five. The headline next to her says: YOU GOT THIS 20,000+ patients chose LUTATHERA for the opportunity to delay NET progression––join in their strength The footnote next to her reads: Actor portrayal.] [H4] LUTATHERA has helped treat over 20,000 patients with NETs, including those: Who have just been diagnosed with faster-growing NETs (Ki-67, 10%–55% [grade 2 or 3]) and are ready for their first treatmentWho added LUTATHERA to their treatment after progressing on SSAs [H4] LUTATHERA can help slow down NET progression for longer. Choosing the right first treatment for you is a big step after diagnosis. You and your doctor can decide if LUTATHERA is the right first step to slow NET progression.See proven results with LUTATHERA [IMG: Early action icon.] [H2] Acting early to slow NETs is an important first stepSee why >NET, neuroendocrine tumor; SSAs, somatostatin analogues.
This page presents a snapshot of public data from Novartis, captured on May 31, 2026, to show how machine logic reads Semantic Coherence signals into an AI reputation evaluation.
Purpose: This data is presented under “Fair Use” for the purpose of independent signal analysis, allowing readers to see the raw signals behind the reputation score.
Notice to Novartis: This analysis is part of a non-adversarial audit conducted by 1 Euro SEO. The results are intended as professional feedback to help improve any website’s machine-readability and authority signals. The evaluation is free, and any company can request a fresh audit at any time.
Any company can use the insights for free and improve its voice. When a company has updated its content, it can always submit a new audit request, which will be reflected in a new current score.
To all users: You are encouraged to visit the live site at https://lutathera.com to view the most current version of its content and see directly what this company is about and what it offers.